Arch Therapeutics Co-Founder Rutledge Ellis-Behnke Delivers Keynote at Nanomaterials Technology Transfer Conference in Corfu, Greece
16 juil. 2013 09h00 HE
|
Arch Therapeutics, Inc.
CAMBRIDGE, MA--(Marketwired - Jul 16, 2013) - Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), a life science company and developer of AC5™, a novel product aimed at...
Arch Therapeutics Appoints Senior Management Team Members
08 juil. 2013 09h00 HE
|
Arch Therapeutics, Inc.
CAMBRIDGE, MA--(Marketwired - Jul 8, 2013) - Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), a life science company and developer of AC5™, a novel product aimed at...
Arch Therapeutics Introduces Experienced Directors and Executive Leadership
02 juil. 2013 09h00 HE
|
Arch Therapeutics, Inc.
CAMBRIDGE, MA--(Marketwired - Jul 2, 2013) - Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), a life science company and developer of AC5™, a novel product aimed at...
Arch Therapeutics Effects Merger to Commence Operations as a Life Science Company
27 juin 2013 17h04 HE
|
Arch Therapeutics, Inc.
CAMBRIDGE, MA--(Marketwired - Jun 27, 2013) - Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company") is pleased to announce the closing of a reverse acquisition merger on June 26, 2013,...
On-X LTI Receives FDA Approval for On-X Heart Valve With Anatomic Shaped Sewing Ring
26 févr. 2013 08h00 HE
|
On-X Life Technologies Inc.
AUSTIN, Texas, Feb. 26, 2013 (GLOBE NEWSWIRE) -- On-X® Life Technologies, Inc. (On-X LTI) announced today that it has received approval from the US Food & Drug Administration (FDA) to market the...
On-X LTI Launches Innovative Heart Valve Products at European Meeting in Barcelona
29 oct. 2012 08h00 HE
|
On-X Life Technologies Inc.
AUSTIN, Texas, Oct. 29, 2012 (GLOBE NEWSWIRE) -- On-X® Life Technologies, Inc. (On-X LTI) announced today that it is launching two new heart valve products, the On-X® Aortic Prosthetic Valve...
Boston Therapeutics Announces Clinical Study Safety Results With SUGARDOWN(R) at University of Sydney
24 janv. 2012 11h40 HE
|
Boston Therapeutics, Inc.
MANCHESTER, N.H., Jan. 24, 2012 (GLOBE NEWSWIRE) -- Boston Therapeutics, Inc. (BTI), a developer of diabetes therapeutics, announced today the clinical trial results in healthy volunteers performed at...
NanoInk Platform Proven to Reproducibly Detect Protein Biomarkers From Dried Blood Spot Samples
19 sept. 2011 09h00 HE
|
NanoInk
SKOKIE, IL--(Marketwire - Sep 19, 2011) - The Nano BioDiscovery Division of NanoInk, Inc.® provides a new generation of array-based instrument systems, assay kits, and contract services for...
Landmark Clinical Research With the On-X Heart Valve in a Poorly Anticoagulated South African Patient Group to be Presented at Major U.S. Heart Centers
01 sept. 2011 07h58 HE
|
On-X Life Technologies Inc.
AUSTIN, Texas, Sept. 1, 2011 (GLOBE NEWSWIRE) -- On-X® Life Technologies, Inc. (On-X LTI) announced today that Mervyn Williams, M.D., of Port Elizabeth, South Africa, will present the results of...
HemoBioTech and Its Innovative Blood Substitute HemoTech Could Benefit From House Resolution to Support Small Biotechnology Companies
25 mars 2010 08h00 HE
|
HemoBioTech
DALLAS, TX--(Marketwire - March 25, 2010) - Congressman Danny K. Davis (Il-7th) recently submitted House Resolution 1179, legislation that puts Congress on record in supporting biotechnology...